Outcomes of Intracorporeal Continuous and Paracorporeal Pulsatile Ventricular Assist Devices in Pediatric Patients

Jacqueline Lee1, Muhammad F Shezad2, Farhan Zafar2

  • 1From the Herma Heart Institute, Children's Wisconsin, and Department of Pediatrics, Section of Critical Care, Medical College of Wisconsin, Milwaukee, Wisconsin.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|February 23, 2024
PubMed

Insights

Outcomes for intracorporeal continuous (IC) and paracorporeal pulsatile (PP) ventricular assist devices (VADs) in pediatric patients showed similar survival. Stroke risk was higher in PP VADs, though not statistically significant.

Area of Science:

  • Pediatric Cardiology
  • Mechanical Circulatory Support
  • Biomedical Engineering

Background:

  • Ventricular assist devices (VADs) are crucial for pediatric heart failure management.
  • Paracorporeal VADs are used when intracorporeal devices are too large for smaller children.
  • The comparative effectiveness of intracorporeal continuous-flow (IC) versus paracorporeal pulsatile-flow (PP) VADs in eligible pediatric patients is not well-defined.

Purpose of the Study:

  • To compare survival and stroke outcomes between IC and PP VADs in pediatric patients.
  • To analyze VAD performance in children weighing 10-30 kg who could potentially receive either device type.

Main Methods:

  • Retrospective analysis of pediatric VAD recipients (10-30 kg) from the ACTION database (June 2018-September 2021).
  • Comparison of survival and stroke rates between IC and PP VAD cohorts.
  • Analysis of patient demographics, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profiles, and diagnoses.

Main Results:

  • The study included 41 patients in the IC group and 54 in the PP group.
  • The PP cohort was younger and smaller, with a higher INTERMACS profile compared to the IC cohort.
  • Overall survival was comparable between IC and PP VADs; stroke events were more frequent in the PP group but not statistically significant (p=0.07).

Conclusions:

  • In pediatric patients eligible for either IC or PP VADs, overall survival was similar.
  • While stroke events trended higher in the PP group, direct comparisons are limited by baseline differences in patient characteristics and acuity.
  • Further research is needed to clarify optimal VAD selection for this patient population.